Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis.

Abstract:

:Renal cell carcinoma (RCC) is the most common primary cancer arising from the kidney in adults, with clear cell renal cell carcinoma (ccRCC) representing approximately 75% of all RCCs. Increased expression of the hypoxia-induced factors-1α (HIF1α) and HIF2α has been suggested as a pivotal step in ccRCC carcinogenesis, but this has not been thoroughly tested. Here, we report that expression of a constitutively activated form of HIF2α (P405A, P530A, and N851A, named as HIF2αM3) in the proximal tubules of mice is not sufficient to promote ccRCC by itself, nor does it enhance HIF1αM3 oncogenesis when coexpressed with constitutively active HIF1αM3. Neoplastic transformation in kidneys was not detected at up to 33 months of age, nor was increased expression of Ki67 (MKI67), γH2AX (H2AFX), or CD70 observed. Furthermore, the genome-wide transcriptome of the transgenic kidneys does not resemble human ccRCC. We conclude that a constitutively active HIF2α is not sufficient to cause neoplastic transformation of proximal tubules, arguing against the idea that HIF2α activation is critical for ccRCC tumorigenesis.

journal_name

Cancer Res

journal_title

Cancer research

authors

Fu L,Wang G,Shevchuk MM,Nanus DM,Gudas LJ

doi

10.1158/0008-5472.CAN-12-3983

subject

Has Abstract

pub_date

2013-05-01 00:00:00

pages

2916-25

issue

9

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-12-3983

journal_volume

73

pub_type

杂志文章
  • Targeted cancer therapeutics.

    abstract::Targeted therapies can be defined as drugs developed against a specific target based on its important biological function in cancer. In contrast, nontargeted therapies are drugs identified by phenotypic screening of natural products or chemical libraries against established cancer cell lines or preclinical animal mode...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-08-3836

    authors: Hait WN,Hambley TW

    更新日期:2009-02-15 00:00:00

  • Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo.

    abstract::The idea of using oncolytic viruses for the treatment of cancers was proposed a century ago. During the last two decades, viruses able to replicate specifically in cancer cells and to induce their lysis were identified and were genetically modified to improve their viro-oncolytic properties. More recently, a new appro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1076

    authors: Gillet L,Dewals B,Farnir F,de Leval L,Vanderplasschen A

    更新日期:2005-10-15 00:00:00

  • Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.

    abstract::Farnesol (FOH) and other isoprenoid alcohols induce apoptosis in various carcinoma cells and inhibit tumorigenesis in several in vivo models. However, the mechanisms by which they mediate their effects are not yet fully understood. In this study, we show that FOH is an effective inducer of apoptosis in several lung ca...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0931

    authors: Joo JH,Liao G,Collins JB,Grissom SF,Jetten AM

    更新日期:2007-08-15 00:00:00

  • HER-2/neu amplification predicts poor survival in node-positive breast cancer.

    abstract::HER-2/neu protooncogene amplification and protein expression were analyzed with slot blot and Western blot techniques, respectively, in more than 300 invasive primary breast tumors of all stages. Amplification (2- greater than 30 copies) was found in 17% of these tumors and high expression was seen in 19%. There was a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Borg A,Tandon AK,Sigurdsson H,Clark GM,Fernö M,Fuqua SA,Killander D,McGuire WL

    更新日期:1990-07-15 00:00:00

  • Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein.

    abstract::The cell line AR230 was established from the peripheral blood mononuclear cells of a patient with chronic myeloid leukemia and t(9;22) translocation bearing a variant type of BCR/ABL rearrangement. AR230 expresses a BCR/ABL fusion protein with a molecular mass of 230 kilodaltons (kDa) due to the insertion of 180 amino...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wada H,Mizutani S,Nishimura J,Usuki Y,Kohsaki M,Komai M,Kaneko H,Sakamoto S,Delia D,Kanamaru A

    更新日期:1995-07-15 00:00:00

  • Inflammatory, proliferative, and neoplastic lesions at the site of metallic identification ear tags in Wistar [Crl:(WI)BR] rats.

    abstract::During a 2-yr study of carcinogenesis by CdCl2 in male Wistar [Crl:(WI)BR] rats, weekly clinical observations during the last 6 mo of the study revealed many cases of persistent tumor-like masses at the site of the metal identification tags in the ears of the animals. A total of 14 tumors (mostly compound osteosarcoma...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Waalkes MP,Rehm S,Kasprzak KS,Issaq HJ

    更新日期:1987-05-01 00:00:00

  • Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells.

    abstract::Photodynamic therapy (PDT), an experimental cancer treatment employing a photosensitizer and visible light, is a highly efficient inducer of apoptosis (or programmed cell death) in mouse L5178Y lymphoma cells, resulting in extensive DNA fragmentation within 1-2 h. The major targets for PDT are in cellular membranes, a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Agarwal ML,Larkin HE,Zaidi SI,Mukhtar H,Oleinick NL

    更新日期:1993-12-15 00:00:00

  • Inverse PCR-based RFLP scanning identifies low-level mutation signatures in colon cells and tumors.

    abstract::Detecting the presence and diversity of low-level mutations in human tumors undergoing genomic instability is desirable due to their potential prognostic value and their putative influence on the ability of tumors to resist drug treatment and/or metastasize. However, direct measurement of these genetic alterations in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-3652

    authors: Liu WH,Kaur M,Wang G,Zhu P,Zhang Y,Makrigiorgos GM

    更新日期:2004-04-01 00:00:00

  • Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.

    abstract::We have evaluated 4 radioiodinated mouse monoclonal anticarcinoembryonic antigen antibodies (MAbs) by using the GW-39 human colorectal tumor xenograft transplanted i.m. in immunocompetent hamsters to determine whether there were any differences in their tumor localization properties. Additional comparisons were made t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sharkey RM,Primus FJ,Shochat D,Goldenberg DM

    更新日期:1988-04-01 00:00:00

  • Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC.

    abstract::SPARC is an extracellular matrix protein that exerts pleiotropic effects on extracellular matrix organization, growth factor availability, cell adhesion, differentiation, and immunity in cancer. Chronic myelogenous leukemia (CML) cells resistant to the BCR-ABL inhibitor imatinib (IM-R cells) were found to overexpress ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2034

    authors: Fenouille N,Puissant A,Dufies M,Robert G,Jacquel A,Ohanna M,Deckert M,Pasquet JM,Mahon FX,Cassuto JP,Raynaud S,Tartare-Deckert S,Auberger P

    更新日期:2010-12-01 00:00:00

  • Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.

    abstract::Donor lymphocyte infusions (DLI) provide effective therapy for patients with multiple myeloma who have relapsed after allogeneic bone marrow transplantation. However, the immunological mechanisms of the graft-versus-myeloma (GVM) effect have not been defined, and the target antigens of this response have not been iden...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Orsini E,Bellucci R,Alyea EP,Schlossman R,Canning C,McLaughlin S,Ghia P,Anderson KC,Ritz J

    更新日期:2003-05-15 00:00:00

  • Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.

    abstract::Patients with disseminated Ewing's family of tumors (ESFT) often experience drug-resistant relapse. We hypothesize that targeting minimal residual disease with the cytotoxic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR; fenretinide) may decrease relapse. We determined the following: (a) 4-HPR cytotoxicity against 12...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0377

    authors: Batra S,Reynolds CP,Maurer BJ

    更新日期:2004-08-01 00:00:00

  • A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.

    abstract::Emerging evidence supporting the activation of the Akt-mammalian target of rapamycin (mTOR) signaling network in head and neck squamous cell carcinoma (HNSCC) progression has provided the rationale for exploring the therapeutic potential of inhibiting this pathway for HNSCC treatment. Indeed, rapamycin, a clinically r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1756

    authors: Amornphimoltham P,Patel V,Leelahavanichkul K,Abraham RT,Gutkind JS

    更新日期:2008-02-15 00:00:00

  • CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.

    abstract::Genetic immunization of mice with dendritic cells (DCs) engineered to express a melanoma antigen generates antigen-specific, MHC-restricted, CD4-dependent protective immune responses. We wanted to determine the role of CD4 cells and CD40 ligation of MART-1 gene-modified DC in an animal model of immunotherapy for murin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ribas A,Butterfield LH,Amarnani SN,Dissette VB,Kim D,Meng WS,Miranda GA,Wang HJ,McBride WH,Glaspy JA,Economou JS

    更新日期:2001-12-15 00:00:00

  • Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.

    abstract::2'-Deoxycoformycin (2'-dCF), a tight-binding inhibitor of adenosine deaminase, was administered to 26 pediatric patients with acute lymphoblastic leukemia in a Phase I study. Doses ranged from 0.25 to 1.0 mg/kg given i.v. for 3 consecutive days. Common toxicity included nausea, vomiting, diarrhea, hepatocellular enzym...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Poplack DG,Sallan SE,Rivera G,Holcenberg J,Murphy SB,Blatt J,Lipton JM,Venner P,Glaubiger DL,Ungerleider R,Johns D

    更新日期:1981-09-01 00:00:00

  • Transfer of tumor cells between cell aggregates as a model for adhesive changes in metastasis.

    abstract::A model for cell detachment which may influence metastasis in vivo is described involving the transfer of hamster melanoma cells from aggregates of those tumor cells to hamster fibroblast aggregates. The aggregates were made by the spontaneous association of cultured cells. Tumor and fibroblast aggregates were then in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Umbreit JN,Erbe RW

    更新日期:1979-06-01 00:00:00

  • Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.

    abstract::Triple-negative breast cancers (TNBC) are especially refractory to treatment due to their negative hormone receptor and ErbB2/HER2 status. Therefore, the identification of cancer-associated deregulated signaling pathways is necessary to develop improved targeted therapies. Here, we show that expression of the ceramide...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3069

    authors: Heering J,Weis N,Holeiter M,Neugart F,Staebler A,Fehm TN,Bischoff A,Schiller J,Duss S,Schmid S,Korte T,Herrmann A,Olayioye MA

    更新日期:2012-06-01 00:00:00

  • NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

    abstract::The NY-ESO-1 gene product is expressed by a range of human tumors and is recognized by antibodies from sera of cancer patients with NY-ESO-1-expressing tumors. The NY-ESO-1 gene also encodes several MHC class I- and MHC class II-restricted tumor epitopes recognized by T lymphocytes. In particular, we previously report...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zarour HM,Maillere B,Brusic V,Coval K,Williams E,Pouvelle-Moratille S,Castelli F,Land S,Bennouna J,Logan T,Kirkwood JM

    更新日期:2002-01-01 00:00:00

  • Cellular heterogeneity in normal and neoplastic human urothelium.

    abstract::Cell suspensions derived from 2 specimens of normal human urothelium and 13 human transitional cell carcinomas were studied by discontinuous density gradient centrifugation. The histochemical and proliferative properties of the fractions were evaluated. In normal urothelium, DNA synthesis was restricted to a subpopula...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mackillop WJ,Bizarri JP,Ward GK

    更新日期:1985-09-01 00:00:00

  • Alteration in binding of dexamethasone to glucocorticoid receptors in regenerating rat liver after partial hepatectomy.

    abstract::Changes in binding of dexamethasone (9 alpha-fluoro-11 beta, 17 alpha, 21-trihydroxy-16 alpha-methylpregna-1,4-diene-3,20-dione) to its receptors in regenerating rat liver after 70% hepatectomy were examined. Specific receptors for dexamethasone in the liver remnants of adrenalectomized rats decreased significantly du...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Isohashi F,Tsukanaka K,Terada M,Nakanishi Y,Fukushima H,Sakamoto Y

    更新日期:1979-12-01 00:00:00

  • Fats and Mets, KRAS-Driven Lipid Dysregulation Affects Metastatic Potential in Pancreatic Cancer.

    abstract::In this issue of Cancer Research, Rozeveld and colleagues present intriguing evidence of the importance of lipid droplets and hormone-sensitive lipase (HSL) in regulating the aggressive nature of pancreatic cancer. Initially demonstrating a dependency of preloaded lipids on an invasive phenotype, the authors then esta...

    journal_title:Cancer research

    pub_type: 评论,杂志文章

    doi:10.1158/0008-5472.CAN-20-3082

    authors: Man J,Pajic M,Joshua AM

    更新日期:2020-11-15 00:00:00

  • Differential EphA2 epitope display on normal versus malignant cells.

    abstract::The EphA2 receptor tyrosine kinase is overexpressed in many different types of human cancers where it functions as a powerful oncoprotein. Dramatic changes in the subcellular localization and function of EphA2 have also been linked with cancer, and in particular, unstable cancer cell-cell contacts prevent EphA2 from s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Coffman KT,Hu M,Carles-Kinch K,Tice D,Donacki N,Munyon K,Kifle G,Woods R,Langermann S,Kiener PA,Kinch MS

    更新日期:2003-11-15 00:00:00

  • Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?

    abstract::Inflammatory pathways may mediate preparation of the "metastatic soil" in the lungs. Some of these pathways--activation and/or the recruitment of certain inflammatory cells--might depend on vascular endothelial growth factor receptor 1 (VEGFR1) activity. Thus, blocking the activity of VEGFR1 (or the interaction with i...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-10-0119

    authors: Duda DG,Jain RK

    更新日期:2010-07-15 00:00:00

  • Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine model.

    abstract::Phase I evaluation of spiromustine was performed using an every-3-week schedule and a weekly X 3 schedule. Neurotoxicity was the dose-limiting toxicity presenting as alterations in cortical integrative functions (orientation, language, coordination), leading to a decrease in the level of consciousness. Traditional cri...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pazdur R,Redman BG,Corbett T,Phillips M,Baker LH

    更新日期:1987-08-01 00:00:00

  • Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer- phenotypes by a series of 1-aryl-3-alkyltriazenes.

    abstract::A series of arylalkyltriazenes has been investigated for its differential cytotoxicity towards the HT-29 (Mer+) and BE (Mer-) cell lines and for its ability to cause DNA strand breaks and cross-links. A monomethyltriazene (MMPT) and some hydroxymethyltriazene derivatives capable of generating the monomethyltriazene in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gibson NW,Hartley JA,LaFrance RJ,Vaughan K

    更新日期:1986-10-01 00:00:00

  • DNA in situ sensitivity to denaturation as a marker of human breast tumors.

    abstract::DNA content and in situ sensitivity to denaturation were analyzed by flow cytometry of individual cell nuclei isolated from 40 breast carcinomas, nine fibroadenomas, and 14 samples of normal breast tissue. The extent of DNA denaturation induced by acid was expressed as alpha t, which represents the fraction of DNA sta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kunicka JE,Olszewski W,Rosen PP,Kimmel M,Melamed MR,Darzynkiewicz Z

    更新日期:1989-11-15 00:00:00

  • ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.

    abstract::Overexpression of the prosurvival Bcl-2 family members (Bcl-2, Bcl-xL, and Mcl-1) is commonly associated with tumor maintenance, progression, and chemoresistance. We previously reported the discovery of ABT-737, a potent, small-molecule Bcl-2 family protein inhibitor. A major limitation of ABT-737 is that it is not or...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5836

    authors: Tse C,Shoemaker AR,Adickes J,Anderson MG,Chen J,Jin S,Johnson EF,Marsh KC,Mitten MJ,Nimmer P,Roberts L,Tahir SK,Xiao Y,Yang X,Zhang H,Fesik S,Rosenberg SH,Elmore SW

    更新日期:2008-05-01 00:00:00

  • Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.

    abstract::Cisplatin (cis-diamminedichloroplatinum, CDDP) is one of the most used drugs for osteosarcoma chemotherapy. By using a series of CDDP-resistant variants, which were established from the U-2OS and Saos-2 human osteosarcoma cell lines, we found that CDDP resistance was mainly associated with the increase of both the int...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5840

    authors: Pasello M,Michelacci F,Scionti I,Hattinger CM,Zuntini M,Caccuri AM,Scotlandi K,Picci P,Serra M

    更新日期:2008-08-15 00:00:00

  • MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers.

    abstract::Transcriptional regulator YAP is activated in multiple human cancers and plays critical roles in tumor initiation, progression, metastasis, and drug resistance. However, therapeutic targeting of the Hippo-YAP pathway has been challenging due to its low druggability and limited knowledge of YAP regulation in cancer. He...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1339

    authors: Seo J,Kim MH,Hong H,Cho H,Park S,Kim SK,Kim J

    更新日期:2019-12-15 00:00:00

  • Identification of compounds selectively killing multidrug-resistant cancer cells.

    abstract::There is a great need for the development of novel chemotherapeutic agents that overcome the emergence of multidrug resistance (MDR) in cancer. We catalogued the National Cancer Institute's DTP drug repository in search of compounds showing increased toxicity in MDR cells. By comparing the sensitivity of parental cell...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2422

    authors: Türk D,Hall MD,Chu BF,Ludwig JA,Fales HM,Gottesman MM,Szakács G

    更新日期:2009-11-01 00:00:00